Tempus AI, Inc. (NASDAQ:TEM) Receives $68.54 Consensus PT from Analysts

Tempus AI, Inc. (NASDAQ:TEM) has been given an average recommendation of “Hold” by the fifteen ratings firms that are currently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and nine have assigned a buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $68.5385.

A number of equities research analysts have recently issued reports on TEM shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tempus AI in a report on Wednesday, June 17th. HC Wainwright lowered their price target on shares of Tempus AI from $95.00 to $64.00 and set a “buy” rating on the stock in a research report on Monday, May 11th. Needham & Company LLC reaffirmed a “buy” rating and set a $75.00 price objective on shares of Tempus AI in a research note on Monday, June 1st. BTIG Research reiterated a “buy” rating and issued a $80.00 price objective on shares of Tempus AI in a report on Monday, June 1st. Finally, TD Cowen lifted their target price on shares of Tempus AI from $65.00 to $68.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th.

Insiders Place Their Bets

In other Tempus AI news, CEO Ryan Fukushima sold 33,284 shares of the business’s stock in a transaction that occurred on Wednesday, July 8th. The stock was sold at an average price of $57.39, for a total value of $1,910,168.76. Following the sale, the chief executive officer owned 167,763 shares of the company’s stock, valued at $9,627,918.57. The trade was a 16.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $46.70, for a total transaction of $7,763,875.00. Following the sale, the chief executive officer directly owned 8,808,533 shares in the company, valued at $411,358,491.10. This represents a 1.85% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 616,043 shares of company stock valued at $31,748,593. 24.26% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Handelsbanken Fonder AB increased its position in shares of Tempus AI by 4.1% in the 2nd quarter. Handelsbanken Fonder AB now owns 32,900 shares of the company’s stock valued at $1,906,000 after purchasing an additional 1,300 shares during the last quarter. CoreCap Advisors LLC lifted its position in shares of Tempus AI by 293.4% during the 2nd quarter. CoreCap Advisors LLC now owns 1,019 shares of the company’s stock worth $59,000 after purchasing an additional 760 shares during the last quarter. NewEdge Advisors LLC grew its stake in shares of Tempus AI by 1.3% during the first quarter. NewEdge Advisors LLC now owns 42,996 shares of the company’s stock worth $1,944,000 after purchasing an additional 536 shares in the last quarter. Avidity Partners Management LP acquired a new position in shares of Tempus AI during the first quarter worth $1,130,000. Finally, Silverback Asset Management LLC increased its holdings in Tempus AI by 44.5% in the first quarter. Silverback Asset Management LLC now owns 35,700 shares of the company’s stock valued at $1,614,000 after buying an additional 11,000 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Price Performance

Shares of TEM traded down $3.27 during trading hours on Friday, hitting $58.23. 4,376,376 shares of the stock were exchanged, compared to its average volume of 5,896,411. The company has a debt-to-equity ratio of 2.96, a quick ratio of 3.15 and a current ratio of 3.31. Tempus AI has a 12-month low of $41.73 and a 12-month high of $104.32. The company has a market cap of $10.46 billion, a price-to-earnings ratio of -33.85 and a beta of 3.46. The stock’s 50-day moving average price is $51.29 and its two-hundred day moving average price is $54.35.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings data on Tuesday, May 5th. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.08. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.The firm had revenue of $348.12 million during the quarter, compared to the consensus estimate of $345.44 million. During the same period in the prior year, the company earned ($0.24) EPS. The firm’s revenue was up 36.1% compared to the same quarter last year. Research analysts expect that Tempus AI will post -1.35 earnings per share for the current year.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.